Integrated therapeutic approaches in head and neck cancer: The importance of multidisciplinary team management

Francesco Perri, Paolo Muto, Corrado Aversa, Antonio Daponte, Giuseppina Della Vittoria, Stefano Pepe, Francesco Caponigro

Research output: Contribution to journalArticle

Abstract

Multidisciplinary team (MDT) is of paramount importance in the approach to patients with head and neck cancer. Its aim is to provide the best diagnostic work-up, tumor staging, and treatment. Furthermore, the prognosis of patients who are managed by MDT is usually better. MDT has a great value in all presentation settings. The role of the pathologist in the team is of utmost importance, in particular with regards to information provided on Human Papilloma Virus (HPV) status, which has a well acknowledged independent prognostic value mainly in oropharyngeal carcinoma. In early stage disease, namely in T1-2 N0 M0 patients, the meetings within the MDT mainly involve surgeons and radiation therapists. Surgery represents the mainstay of treatment, while radiation therapy is a suitable alternative, in particular in patients with advanced age, poor performance status and comorbidities. In locally advanced disease, surgeons, medical oncologists and radiotherapists are the key people, since different approaches have been carried out. In operable patients, adjuvant chemoradiation is indicated when resection margins are involved or close, or in presence of extracapsular nodal spread. Concurrent chemoradiotherapy, preceeded or not by induction chemotherapy, is the favourite approach in this setting when surgery is strictly not indicated. In recurrent/metastatic disease chemotherapy and best supportive care are the main options, although local treatments, such as reirradiation and salvage surgery, are also worth considering. The standard chemotherapy treatment has finally evolved after about 30 years, and strong efforts are being pursued to further improve the outcome, mainly with the addition of new drugs.

Original languageEnglish
Pages (from-to)834-843
Number of pages10
JournalAnti-Cancer Agents in Medicinal Chemistry
Volume13
Issue number6
DOIs
Publication statusPublished - 2013

Fingerprint

Head and Neck Neoplasms
Papillomaviridae
Therapeutics
Drug Therapy
Induction Chemotherapy
Neoplasm Staging
Chemoradiotherapy
Comorbidity
Radiotherapy
Radiation
Carcinoma
Pharmaceutical Preparations
Surgeons

Keywords

  • Early stage
  • Head and neck cancer
  • Locally advanced disease
  • Multidisciplinary team
  • Pathologist
  • Recurrent/metastatic disease

ASJC Scopus subject areas

  • Cancer Research
  • Molecular Medicine
  • Pharmacology

Cite this

Integrated therapeutic approaches in head and neck cancer : The importance of multidisciplinary team management. / Perri, Francesco; Muto, Paolo; Aversa, Corrado; Daponte, Antonio; Vittoria, Giuseppina Della; Pepe, Stefano; Caponigro, Francesco.

In: Anti-Cancer Agents in Medicinal Chemistry, Vol. 13, No. 6, 2013, p. 834-843.

Research output: Contribution to journalArticle

@article{25b9f735c70d4cdb984402b7e6cf1b6a,
title = "Integrated therapeutic approaches in head and neck cancer: The importance of multidisciplinary team management",
abstract = "Multidisciplinary team (MDT) is of paramount importance in the approach to patients with head and neck cancer. Its aim is to provide the best diagnostic work-up, tumor staging, and treatment. Furthermore, the prognosis of patients who are managed by MDT is usually better. MDT has a great value in all presentation settings. The role of the pathologist in the team is of utmost importance, in particular with regards to information provided on Human Papilloma Virus (HPV) status, which has a well acknowledged independent prognostic value mainly in oropharyngeal carcinoma. In early stage disease, namely in T1-2 N0 M0 patients, the meetings within the MDT mainly involve surgeons and radiation therapists. Surgery represents the mainstay of treatment, while radiation therapy is a suitable alternative, in particular in patients with advanced age, poor performance status and comorbidities. In locally advanced disease, surgeons, medical oncologists and radiotherapists are the key people, since different approaches have been carried out. In operable patients, adjuvant chemoradiation is indicated when resection margins are involved or close, or in presence of extracapsular nodal spread. Concurrent chemoradiotherapy, preceeded or not by induction chemotherapy, is the favourite approach in this setting when surgery is strictly not indicated. In recurrent/metastatic disease chemotherapy and best supportive care are the main options, although local treatments, such as reirradiation and salvage surgery, are also worth considering. The standard chemotherapy treatment has finally evolved after about 30 years, and strong efforts are being pursued to further improve the outcome, mainly with the addition of new drugs.",
keywords = "Early stage, Head and neck cancer, Locally advanced disease, Multidisciplinary team, Pathologist, Recurrent/metastatic disease",
author = "Francesco Perri and Paolo Muto and Corrado Aversa and Antonio Daponte and Vittoria, {Giuseppina Della} and Stefano Pepe and Francesco Caponigro",
year = "2013",
doi = "10.2174/18715206113139990110",
language = "English",
volume = "13",
pages = "834--843",
journal = "Anti-Cancer Agents in Medicinal Chemistry",
issn = "1871-5206",
publisher = "Bentham Science Publishers B.V.",
number = "6",

}

TY - JOUR

T1 - Integrated therapeutic approaches in head and neck cancer

T2 - The importance of multidisciplinary team management

AU - Perri, Francesco

AU - Muto, Paolo

AU - Aversa, Corrado

AU - Daponte, Antonio

AU - Vittoria, Giuseppina Della

AU - Pepe, Stefano

AU - Caponigro, Francesco

PY - 2013

Y1 - 2013

N2 - Multidisciplinary team (MDT) is of paramount importance in the approach to patients with head and neck cancer. Its aim is to provide the best diagnostic work-up, tumor staging, and treatment. Furthermore, the prognosis of patients who are managed by MDT is usually better. MDT has a great value in all presentation settings. The role of the pathologist in the team is of utmost importance, in particular with regards to information provided on Human Papilloma Virus (HPV) status, which has a well acknowledged independent prognostic value mainly in oropharyngeal carcinoma. In early stage disease, namely in T1-2 N0 M0 patients, the meetings within the MDT mainly involve surgeons and radiation therapists. Surgery represents the mainstay of treatment, while radiation therapy is a suitable alternative, in particular in patients with advanced age, poor performance status and comorbidities. In locally advanced disease, surgeons, medical oncologists and radiotherapists are the key people, since different approaches have been carried out. In operable patients, adjuvant chemoradiation is indicated when resection margins are involved or close, or in presence of extracapsular nodal spread. Concurrent chemoradiotherapy, preceeded or not by induction chemotherapy, is the favourite approach in this setting when surgery is strictly not indicated. In recurrent/metastatic disease chemotherapy and best supportive care are the main options, although local treatments, such as reirradiation and salvage surgery, are also worth considering. The standard chemotherapy treatment has finally evolved after about 30 years, and strong efforts are being pursued to further improve the outcome, mainly with the addition of new drugs.

AB - Multidisciplinary team (MDT) is of paramount importance in the approach to patients with head and neck cancer. Its aim is to provide the best diagnostic work-up, tumor staging, and treatment. Furthermore, the prognosis of patients who are managed by MDT is usually better. MDT has a great value in all presentation settings. The role of the pathologist in the team is of utmost importance, in particular with regards to information provided on Human Papilloma Virus (HPV) status, which has a well acknowledged independent prognostic value mainly in oropharyngeal carcinoma. In early stage disease, namely in T1-2 N0 M0 patients, the meetings within the MDT mainly involve surgeons and radiation therapists. Surgery represents the mainstay of treatment, while radiation therapy is a suitable alternative, in particular in patients with advanced age, poor performance status and comorbidities. In locally advanced disease, surgeons, medical oncologists and radiotherapists are the key people, since different approaches have been carried out. In operable patients, adjuvant chemoradiation is indicated when resection margins are involved or close, or in presence of extracapsular nodal spread. Concurrent chemoradiotherapy, preceeded or not by induction chemotherapy, is the favourite approach in this setting when surgery is strictly not indicated. In recurrent/metastatic disease chemotherapy and best supportive care are the main options, although local treatments, such as reirradiation and salvage surgery, are also worth considering. The standard chemotherapy treatment has finally evolved after about 30 years, and strong efforts are being pursued to further improve the outcome, mainly with the addition of new drugs.

KW - Early stage

KW - Head and neck cancer

KW - Locally advanced disease

KW - Multidisciplinary team

KW - Pathologist

KW - Recurrent/metastatic disease

UR - http://www.scopus.com/inward/record.url?scp=84880140312&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84880140312&partnerID=8YFLogxK

U2 - 10.2174/18715206113139990110

DO - 10.2174/18715206113139990110

M3 - Article

C2 - 23194421

AN - SCOPUS:84880140312

VL - 13

SP - 834

EP - 843

JO - Anti-Cancer Agents in Medicinal Chemistry

JF - Anti-Cancer Agents in Medicinal Chemistry

SN - 1871-5206

IS - 6

ER -